An exterior view of the European Medicines Agency, EMA, in Amsterdam's business district, Netherlands, on 20 April 2021.

The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended the approval of Vyjuvek for the ...

European Union's human medicines committee (CHMP) said on Friday it is not updating its opinion on Eisai and Biogen's ...

Krystal Biotech (KRYS) has received a positive recommendation from EU regulators for its drug Vyjuvek for the treatment of ...

Right now, Rinvoq is approved in the European Union and the U.S. for the treatment of adults with radiographic axial ...

Vertex Pharmaceuticals (VRTX) stock in focus as company secures EU backing to expand label for its cystic fibrosis therapy ...

The European Medicines Agency (EMA) said Votrient (pazopanib) can affect melanin production in patients. The EMA reports that among the most common side effects of Votrient, occurring in more than 1 ...

Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...

Results of the Planned Interim Analysis and Update on Topline Read-out for the Essential3 Program: The Independent Data ...

Medicines account for more than 13 per cent – about €3.3 billion – of a health budget that is permanently under strain. That ...

Eli Lilly (LLY) and Company announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive ...

Neurotech International has received positive feedback from the European Medicines Agency (EMA) on the company’s Orphan ...